| Mar 2, 2026 |
Mar 6, 2026 |
Elston George
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 4, 2026 |
Mar 5, 2026 |
Ribeiro Ramiro
|
Chief Medical Officer |
Sell |
26.3
|
-2,438
|
-100.00%
|
✗
|
$43.6K |
| Feb 17, 2026 |
Feb 18, 2026 |
Ribeiro Ramiro
|
Chief Medical Officer |
Sell |
26.3
|
-2,437
|
-100.00%
|
✗
|
$36.6K |
| Jan 6, 2026 |
Jan 7, 2026 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2026 |
Jan 7, 2026 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-10,054
|
-5.38%
|
✗
|
$169.5K |
| Jan 6, 2026 |
Jan 7, 2026 |
Elston George
|
CFO |
Sell |
42.5
|
-4,487
|
-3.70%
|
✗
|
$75.7K |
| Jan 5, 2026 |
Jan 7, 2026 |
Ribeiro Ramiro
|
Chief Medical Officer |
Sell |
20.0
|
-42,544
|
-100.00%
|
✗
|
$727.3K |
| Jan 3, 2026 |
Jan 6, 2026 |
Ribeiro Ramiro
|
Chief Medical Officer |
Sell |
42.5
|
-6,373
|
-32.40%
|
✗
|
$111.4K |
| Jan 3, 2026 |
Jan 6, 2026 |
Duker Jay S.
|
CEO |
Sell |
40.0
|
-37,952
|
-14.85%
|
✗
|
$662.7K |
| Jan 3, 2026 |
Jan 6, 2026 |
Elston George
|
CFO |
Sell |
42.5
|
-10,727
|
-5.73%
|
✗
|
$187.3K |
| Jan 2, 2026 |
Jan 6, 2026 |
Zaderej Karen L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Sanders Reginald J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2026 |
Jan 6, 2026 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Landis John B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Duty Stuart
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
Hassan Fred
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
DICICCO WENDY F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 2, 2026 |
Jan 6, 2026 |
ANDO GORAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 19, 2025 |
Dec 23, 2025 |
Elston George
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Dec 4, 2025 |
Dec 8, 2025 |
Cormorant Asset Management, LP
|
Other |
Sell |
30.0
|
-60,000
|
-0.72%
|
✗
|
$942.2K |
| Dec 4, 2025 |
Dec 5, 2025 |
Lurker Nancy
|
Director |
Sell |
22.5
|
-9,300
|
-2.71%
|
✗
|
$140.5K |
| Nov 26, 2025 |
Dec 1, 2025 |
Lurker Nancy
|
Director |
Sell |
43.8
|
-700
|
-0.20%
|
✗
|
$10.5K |
| Nov 11, 2025 |
Nov 12, 2025 |
Ribeiro Ramiro
|
Chief Medical Officer |
Sell |
26.3
|
-2,722
|
-100.00%
|
✗
|
$31.6K |
| Sep 19, 2025 |
Sep 22, 2025 |
Elston George
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2025 |
Jul 11, 2025 |
Zaderej Karen L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 10, 2025 |
Jul 11, 2025 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 10, 2025 |
Jul 11, 2025 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-7,688
|
-6.58%
|
✗
|
$85K |
| Jul 2, 2025 |
Jul 2, 2025 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2025 |
Jun 25, 2025 |
Duker Jay S.
|
CEO |
Sell |
20.0
|
-56,665
|
-36.13%
|
✗
|
$465.2K |
| May 25, 2025 |
May 27, 2025 |
Elston George
|
CFO |
Sell |
46.3
|
-2,202
|
-2.65%
|
✗
|
$12.5K |
| May 16, 2025 |
May 19, 2025 |
Zaderej Karen L.
|
Director |
Buy |
95.0
|
+10,000
|
37.74%
|
✗
|
$59K |
| May 14, 2025 |
May 15, 2025 |
Zaderej Karen L.
|
Director |
Buy |
95.0
|
+10,000
|
60.61%
|
✗
|
$54.5K |
| Mar 19, 2025 |
Mar 20, 2025 |
Duker Jay S.
|
CEO |
Sell |
22.5
|
-20,000
|
-16.65%
|
✗
|
$123.1K |
| Feb 9, 2025 |
Feb 11, 2025 |
Elston George
|
CFO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2025 |
Feb 11, 2025 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2025 |
Feb 11, 2025 |
Duker Jay S.
|
CEO |
Sell |
46.3
|
-2,055
|
-2.01%
|
✗
|
$13.3K |
| Jan 8, 2025 |
Jan 8, 2025 |
Sanders Reginald J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Jan 8, 2025 |
Sanders Reginald J.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
Hassan Fred
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
Zaderej Karen L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
ANDO GORAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
Duty Stuart
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
DICICCO WENDY F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 3, 2025 |
Jan 7, 2025 |
Ribeiro Ramiro
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2025 |
Jan 7, 2025 |
Elston George
|
CFO |
Sell |
42.5
|
-10,075
|
-7.37%
|
✗
|
$85.2K |
| Jan 5, 2025 |
Jan 7, 2025 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2025 |
Jan 7, 2025 |
Landis John B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2025 |
Jan 7, 2025 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-16,115
|
-9.52%
|
✗
|
$135.7K |
|
Sep 5, 2024 |
Hassan Fred
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 3, 2024 |
Sep 5, 2024 |
Hassan Fred
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Aug 20, 2024 |
Aug 21, 2024 |
DICICCO WENDY F
|
Director |
Buy |
91.3
|
+2,567
|
34.69%
|
✗
|
$20K |
| Aug 21, 2024 |
Aug 21, 2024 |
ANDO GORAN
|
Director |
Buy |
91.3
|
+5,000
|
61.35%
|
✗
|
$39.8K |
| Aug 19, 2024 |
Aug 21, 2024 |
Zaderej Karen L.
|
Director |
Buy |
95.0
|
+12,500
|
312.50%
|
✗
|
$99.8K |
| Aug 16, 2024 |
Aug 20, 2024 |
Lurker Nancy
|
Director |
Buy |
78.8
|
+3,173
|
1.43%
|
✗
|
$25K |
| Jul 26, 2024 |
Jul 26, 2024 |
Lurker Nancy
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 12, 2024 |
Jul 16, 2024 |
GUYER DAVID R
|
Director |
Sell |
22.5
|
-11,625
|
-86.27%
|
✗
|
$117K |
| Jul 10, 2024 |
Jul 12, 2024 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-8,059
|
-11.75%
|
✗
|
$70K |
| Jul 10, 2024 |
Jul 12, 2024 |
Lurker Nancy
|
Chair |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 11, 2024 |
Jul 12, 2024 |
Zaderej Karen L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 23, 2024 |
Jun 25, 2024 |
ADAMIS ANTHONY P
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jun 3, 2024 |
Jun 4, 2024 |
GUYER DAVID R
|
Director |
Sell |
22.5
|
-11,625
|
-75.86%
|
✗
|
$119.7K |
| May 25, 2024 |
May 28, 2024 |
Elston George
|
CFO |
Sell |
46.3
|
-3,627
|
-7.10%
|
✗
|
$40.5K |
| May 14, 2024 |
May 16, 2024 |
GUYER DAVID R
|
Director |
Sell |
22.5
|
-11,625
|
-67.69%
|
✗
|
$147K |
| May 6, 2024 |
May 8, 2024 |
Cormorant Asset Management, LP
|
10% Owner |
Buy |
100.0
|
+850,000
|
11.37%
|
✗
|
$10.1M |
|
Apr 22, 2024 |
Adage Capital Management, L.P.
|
10% Owner |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 18, 2024 |
Apr 22, 2024 |
Cormorant Asset Management, LP
|
10% Owner |
Buy |
97.5
|
+581,765
|
8.44%
|
✗
|
$10.5M |
| Mar 30, 2024 |
Apr 2, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
40.0
|
-25,546
|
-27.58%
|
✗
|
$528K |
| Mar 1, 2024 |
Mar 4, 2024 |
Ribeiro Ramiro
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
|
Mar 4, 2024 |
Ribeiro Ramiro
|
Chief Medical Officer |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 27, 2024 |
Feb 28, 2024 |
Duker Jay S.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 20, 2024 |
Feb 22, 2024 |
Duker Jay S.
|
CEO |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Feb 9, 2024 |
Feb 13, 2024 |
Lurker Nancy
|
Chair |
Sell |
40.0
|
-14,943
|
-6.64%
|
✗
|
$430.4K |
| Feb 9, 2024 |
Feb 13, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
42.5
|
-5,083
|
-10.75%
|
✗
|
$146.4K |
| Feb 9, 2024 |
Feb 13, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
42.5
|
-3,656
|
-7.53%
|
✗
|
$105.3K |
| Feb 9, 2024 |
Feb 13, 2024 |
Elston George
|
CFO |
Sell |
42.5
|
-3,192
|
-6.82%
|
✗
|
$91.9K |
| Feb 9, 2024 |
Feb 13, 2024 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-3,533
|
-6.37%
|
✗
|
$101.8K |
| Feb 2, 2024 |
Feb 5, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
37.5
|
-209
|
-0.55%
|
✗
|
$6K |
| Jan 26, 2024 |
Jan 30, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
17.5
|
-49,325
|
-57.47%
|
✗
|
$1.3M |
| Jan 26, 2024 |
Jan 29, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-26,017
|
-40.66%
|
✗
|
$660.4K |
| Jan 25, 2024 |
Jan 29, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
26.3
|
-600
|
-1.62%
|
✗
|
$15K |
| Jan 24, 2024 |
Jan 26, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-11,900
|
-7.01%
|
✗
|
$297.6K |
| Jan 23, 2024 |
Jan 25, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
20.0
|
-16,386
|
-9.57%
|
✗
|
$409.8K |
| Jan 23, 2024 |
Jan 25, 2024 |
Lurker Nancy
|
Chair |
Sell |
20.0
|
-35,000
|
-15.72%
|
✗
|
$874.2K |
| Jan 22, 2024 |
Jan 24, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
20.0
|
-35,066
|
-16.22%
|
✗
|
$795.2K |
| Jan 11, 2024 |
Jan 16, 2024 |
Ocumension Therapeutics
|
Director |
Sell |
15.0
|
-1,910,500
|
-95.02%
|
✗
|
$37.2M |
| Jan 11, 2024 |
Jan 16, 2024 |
Liu Ye
|
Director |
Sell |
15.0
|
-1,910,500
|
-95.02%
|
✗
|
$37.2M |
| Jan 9, 2024 |
Jan 11, 2024 |
Cormorant Asset Management, LP
|
10% Owner |
Buy |
100.0
|
+855,000
|
14.16%
|
✗
|
$17.1M |
| Jan 8, 2024 |
Jan 10, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
20.0
|
-22,913
|
-38.56%
|
✗
|
$484.1K |
| Jan 6, 2024 |
Jan 9, 2024 |
Paggiarino Dario A.
|
Chief Medical Officer |
Sell |
42.5
|
-4,487
|
-10.95%
|
✗
|
$91.5K |
| Jan 6, 2024 |
Jan 9, 2024 |
Lurker Nancy
|
Chair |
Sell |
40.0
|
-23,043
|
-11.91%
|
✗
|
$470.1K |
| Jan 5, 2024 |
Jan 9, 2024 |
Zaderej Karen L.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 6, 2024 |
Jan 9, 2024 |
Pine Michael Craig
|
Chief Corp Dev.&Strat. Officer |
Sell |
42.5
|
-5,966
|
-30.40%
|
✗
|
$121.7K |
| Jan 6, 2024 |
Jan 9, 2024 |
Jones David Scott
|
SVP & Chief Commercial Officer |
Sell |
42.5
|
-4,147
|
-9.85%
|
✗
|
$84.6K |
| Jan 6, 2024 |
Jan 9, 2024 |
Duker Jay S.
|
CEO |
Sell |
42.5
|
-6,528
|
-13.05%
|
✗
|
$133.2K |
| Jan 6, 2024 |
Jan 9, 2024 |
Elston George
|
CFO |
Sell |
42.5
|
-4,911
|
-12.21%
|
✗
|
$100.2K |
| Jan 5, 2024 |
Jan 9, 2024 |
GUYER DAVID R
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2024 |
Jan 9, 2024 |
Landis John B.
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2024 |
Jan 9, 2024 |
Duty Stuart
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2024 |
Jan 9, 2024 |
DICICCO WENDY F
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jan 5, 2024 |
Jan 9, 2024 |
ANDO GORAN
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |